abstract |
Methods and uses for treatment of dyslipidemia comprising administration of a GLP-1 compound and another antidyslipidemic drug. The antidyslipidemic drug is chosen from a stain, a squalene synthase inhibitor, a bile acid binding resin and an ABIT inhibitor. |